WASHINGTON, D.C.—Patients with an endovascular aneurysm repair (EVAR) should be considered a high-risk group for renal artery interventions and receive closer post-procedure surveillance.

GRAPEVINE, Tex.—Higher levels of 25-hydroxyvitamin D (25 [OH] D) may lower the risk of anemia and elevated C-reactive protein levels may raise the risk, according to new study findings that may explain much of the high prevalence of anemia among individuals with kidney disease, researchers conclude.

STOCKHOLM—Hematide doses administered every four weeks (Q4W) maintains long-term mean hemoglobin levels between 11 and 12 g/dL in CKD patients, and it is well tolerated, according to preliminary data from an ongoing phase II trial.

TORONTO—Nearly one third of women with CKD are taking at least five medications, according to researchers.

STOCKHOLM—More than one third of patients with stage III-IV CKD have restless legs syndrome (RLS), an Italian study found.

GRAPEVINE, Tex.—Higher levels of 25-hydroxyvitamin D (25 (OH) D) may lower the risk of anemia and elevated C-reactive protein levels may raise the risk, according to new study findings that may explain much of the high prevalence of anemia among individuals with kidney disease, researchers conclude.

AMAG Pharmaceuticals, Inc., of Cambridge, Mass., has announced that the FDA has accepted for standard review its New Drug Application (NDA) for ferumoxytol as an IV treatment of iron deficiency anemia in CKD patients.

UNIVERSAL ACCESS to health care might help to overcome racial and ethnic barriers to treatment for kidney disease, according to two studies.

THE PREVALENCE of CKD among adults in Beijing, China is 13%, according to a recent study published in the American Journal of Kidney Diseases (2008;51:373-384).

AT PRESENT, almost one fourth of stage 5 CKD patients experience a life-threatening episode of hyperkalemia requiring emergency treatment, according to data cited in a recent article in Seminars in Dialysis (2007;20:431-439). The authors, Nirupama Putcha, MD, and Michael Allon, MD, note that although "many options have been proposed for the prevention of interdialytic hyperkalemia...prevention currently rests largely upon compliance with diet and a thoughtful use of medication regimens."